Author

Niko Pinter

University of FreiburgORCID 0000-0002-8241-6821Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:proteomics· 3 Approach:statistical model· 3 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2

Frequent Co-Authors

Miguel Cosenza‐ContrerasiD· 3 shared Oliver SchillingiD· 3 shared Tilman WerneriD· 2 shared Tobias FeileniD· 2 shared Agnes Schäfer· 1 shared Alexander GroteiD· 1 shared Antonia Elsässer· 1 shared Axel PagenstecheriD· 1 shared

Activity by Year

2024-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Miguel Cosenza‐ContrerasORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Molecular BiologybioRxivPreprintOct 23, 2025

Proteomic characterization of sporadic clear cell renal cell carcinoma reveals a matrix-dense pseudocapsule and heterogeneous tumor subtypes

Tobias Feilen, Grigor Andreev, Manuel Rogg…·Oliver Schilling

This study uses proteomics to characterize sporadic ccRCC, identifying a matrix-dense pseudocapsule and five tumor subtypes with distinct biological features.

DOI 10.1101/2025.10.23.683844

humanproteomics

𝕏 PostBluesky

Cancer BiologybioRxivPreprintFeb 29, 2024

Proteomic profiling of IDH-wildtype Glioblastoma Tissue and Serum uncovers prognostic Subtypes and Marker Candidates

Tilman Werner, Agnes Schäfer, Michael Hennes…·Oliver Schilling

This study identifies proteomic subtypes and recurrence patterns in IDH-wildtype glioblastoma using tissue and serum samples, revealing prognostic markers and proteomic plasticity in recurrent tumors.

1 citation

humanproteomics

𝕏 PostBluesky

Cancer BiologybioRxivPreprintFeb 28, 2024

Proteomic Characterization of Intrahepatic Cholangiocarcinoma Identifies Distinct Subgroups and Proteins Associated with Time-To-Recurrence

Tilman Werner, Klara-Luisa Budau, Miguel Cosenza‐Contreras…·Oliver Schilling

This study identifies two proteomic subgroups of intrahepatic cholangiocarcinoma with distinct time-to-recurrence rates and biological processes.

DOI 10.1101/2024.02.28.582093

humanproteomics

𝕏 PostBluesky